MedPath
HSA Approval

CEPHALEN CAPSULE 250 mg

SIN09644P

CEPHALEN CAPSULE 250 mg

CEPHALEN CAPSULE 250 mg

February 18, 1998

PHARMATECH MEDICAL ENTERPRISE PTE LTD

PHARMATECH MEDICAL ENTERPRISE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMATECH MEDICAL ENTERPRISE PTE LTD
Licence HolderPHARMATECH MEDICAL ENTERPRISE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

J01DB01

cefalexin

Manufacturer Information

PHARMATECH MEDICAL ENTERPRISE PTE. LTD.

BEXIMCO PHARMACEUTICALS LTD

Active Ingredients

CEFALEXIN

250 mg

Cephalexin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CEPHALEN CAPSULE 250 mg - HSA Approval | MedPath